FDA
-
-
-
-
-
-
-
Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements
-
-
-
-
-
-
-
Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements
-
-
-
-
-
-
-
Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements
-
-
-
-
-
-
-
Tarsus to Host Virtual Investor Webcast Highlighting the Commercialization Strategy, Plans and Progress for TP-03, Its Potential Treatment for Demodex Blepharitis
-
-
-
-
-
-
-
Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer
-
-
-
-
-
-
-
Tarsus Added to NASDAQ Biotechnology Index
-
-
-
-
-
-
-
Tarsus to Present Additional Saturn-2 Pivotal Phase 3 Trial Data at the American Academy of Optometry 2022 Annual Meeting
-
251,413 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All